![Karen Ferrante](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Karen Ferrante
Director/Board Member at MACROGENICS, INC.
Net worth: 63 521 $ as of 30/05/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Scott Koenig | M | 71 | 24 years | |
Jessica Sachs | M | 49 | 12 years | |
David Mims | M | 60 | 5 years | |
Peter Harwin | M | 38 | 4 years | |
Andrew Robbins | M | 48 | 4 years | |
Douglas Lankler | M | 58 | 25 years | |
Margaret Liu | M | 67 | 1 years | |
James Karrels | M | 57 | 16 years | |
Chris Cain | M | 40 | 4 years | |
Evan Kearns | M | 43 | 3 years | |
Jay Siegel | M | 71 | 7 years | |
Jeffrey Peters | M | 53 | 9 years | |
Eric Risser | M | 51 | 15 years | |
Meenu Chhabra Karson | F | 51 | 1 years | |
Todd Shegog | M | 59 | 3 years | |
Matthew Ros | M | 57 | 5 years | |
Arlene Morris | F | 72 | 5 years | |
Edward Hurwitz | M | 60 | 20 years | |
Paul Carter | M | 63 | 7 years | |
William Heiden | M | 64 | 2 years | |
John Green | M | 43 | 6 years | |
David Stump | M | 74 | 11 years | |
Scott Jackson | M | 59 | 7 years | |
Lynn Cilinski | F | 66 | 21 years | |
Federica O’Brien | F | 66 | 3 years | |
Graeme Jack | M | 73 | 7 years | |
Karen Atkin | M | 58 | 3 years | |
Markus Green | M | - | 18 years | |
Selina Zhang | F | - | 2 years | |
Michael Shi | M | 59 | 2 years | |
Mike McDermott | M | 58 | 21 years | |
Christopher O'Reilly | M | - | 13 years | |
Barbara Dalton | M | 69 | 17 years | |
Dana Martin | M | - | 3 years | |
Sara Saltzman | F | - | 5 years | |
John Robinson | M | 50 | 3 years | |
Stephen Eck | M | 69 | 4 years | |
Suneet Varma | M | 55 | 23 years | |
Mwana Lugogo | M | 54 | 12 years | |
Christi Waarich | F | - | - | |
Rachael Easton | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Chuck Wilson | M | 59 | 6 years | |
Mark Robert Baker | M | 69 | 14 years | |
Jeffrey Kindler | M | 68 | 8 years | |
Henry McKinnell | M | 81 | 8 years | |
Patrick Fabbio | M | 56 | 5 years | |
Nicole S. Williams | F | 79 | 12 years | |
Paulo Costa | M | 73 | 13 years | |
Iwaaki Taniguchi | M | - | - | |
George A. Lorch | M | 82 | 15 years | |
Shiro Kuniya | M | 67 | - | |
Angelo William Lovallo | M | 59 | 7 years | |
Christian Hogg | M | 58 | 16 years | |
Christiana Stamoulis | F | 53 | 4 years | |
Peter J. Crowley | M | 65 | 10 years | |
Bruce Booth | M | 49 | 6 years | |
Dennis Ausiello | M | 78 | 13 years | |
Ludwig Hantson | M | 61 | 1 years | |
Paul Fitzhenry | M | 64 | 4 years | |
Mary Heino | F | 64 | - | |
Frank Morich | M | 69 | 4 years | |
Fumio Sudo | M | 83 | 6 years | |
Robert Perez | M | 59 | 1 years | |
Christopher S. James | M | - | 1 years | |
Liam Ratcliffe | M | 60 | 4 years | |
Campbell Murray | M | 48 |
Tokai Pharmaceuticals, Inc.
![]() Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | 5 years |
Susan Stewart | F | 64 |
Tokai Pharmaceuticals, Inc.
![]() Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | 6 years |
Christopher Huang | M | 72 | 11 years | |
Jacob M. Plotsker | M | 56 | 16 years | |
Everett Cunningham | M | 57 | 9 years | |
Stephen Buckley | M | 74 |
Tokai Pharmaceuticals, Inc.
![]() Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | - |
Jonathan Emms | M | - | 20 years | |
Antonio Gualberto | M | 59 |
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 13 years |
Reinhard Ambros | M | 67 |
Tokai Pharmaceuticals, Inc.
![]() Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | 5 years |
Matthew Fust | M | 59 | 6 years | |
Olivier Brandicourt | M | 68 | 13 years | |
Tadataka Yamada | M | 78 | 4 years | |
Marsha Fanucci | F | 70 |
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 5 years |
Blake E. Devitt | M | 77 | 1 years | |
Michael R. Jirousek | M | 65 | 5 years | |
Cheryl Cohen | F | 58 |
Tokai Pharmaceuticals, Inc.
![]() Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | 5 years |
Gail Fosler | F | 76 | 1 years | |
Albert P. L. Stroucken | M | 76 | 1 years | |
William Herbert Gray | M | 82 | 13 years | |
Charles Homcy | M | 75 |
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 6 years |
George Milne | M | 80 | 32 years | |
David Scheinberg | M | 68 | 25 years | |
Nancy Simonian | M | 63 |
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 10 years |
Robert J. Israel | M | 67 | 21 years | |
Michael Kishbauch | M | 75 | 6 years | |
Jörn Aldag | M | 65 | 4 years | |
Ken Galbraith | M | 61 | 14 years | |
James R. Gavin | M | 78 | 1 years | |
Yorihiko Kojima | M | 82 | - | |
Michael William Davis Howell | M | 76 | 11 years | |
Hiroshi Shinha | M | - | 38 years | |
Matthew Osborne | M | - | 1 years | |
John D. Forsyth | M | 76 | 1 years | |
Alexandra Kropotova | M | 51 | 5 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 82 | 82.83% |
Japan | 10 | 10.10% |
Hong Kong | 8 | 8.08% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Karen Ferrante
- Personal Network